LOW
43
-6
EMC
47
11
DTE
38
-4
TXT
82
4
GILD
56
6
ESS
40
-5
EQIX
64
5
CCL
81
16
AIV
37
-2
AKAM
64
2
ITW
37
-2
NWSA
64
-15
CRM
70
18
PCG
74
2
BIIB
50
4
KIM
50
-3
GD
62
5
PLD
30
2
VRTX
53
5
PSA
35
-11
LOW
43
-6
EMC
47
11
DTE
38
-4
TXT
82
4
GILD
56
6
ESS
40
-5
EQIX
64
5
CCL
81
16
AIV
37
-2
AKAM
64
2
ITW
37
-2
NWSA
64
-15
CRM
70
18
PCG
74
2
BIIB
50
4
KIM
50
-3
GD
62
5
PLD
30
2
VRTX
53
5
PSA
35
-11
Financhill
Back

ProShares UltraShort MSCI Emerging Markets Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
35

EEV
ProShares UltraShort MSCI Emerging Markets

Last Price:
$19.64
Seasonality Move:
-4.52%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
35
ProShares UltraShort MSCI Emerging Markets (EEV) is a Sell

Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $19.72. The Score for EEV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • EEV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EEV Stock Price Chart

What is ProShares UltraShort MSCI Emerging Markets's stock price today?

  • The ProShares UltraShort MSCI Emerging Markets share price today is $19.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEV is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

EEV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 48.08 Sell
Chaikin Money Flow: 2846 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.54 - 20.28) Sell
Bollinger Bands (100): (19.21 - 22.79) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

EEV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.91 Sell
20-day SMA: 19.9 Sell
50-day SMA: 19.67 Buy
200-day SMA: 24.88 Sell
8-day EMA: 19.96 Sell
20-day EMA: 19.86 Sell
50-day EMA: 20.07 Sell
200-day EMA: 24.14 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

ProShares UltraShort MSCI Emerging Markets Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):